Status:
COMPLETED
Clinical RD (Respiratory Distress) Score for Objective Decision Making for Surfactant Therapy
Lead Sponsor:
Lady Hardinge Medical College
Conditions:
Respiratory Distress Syndrome in Premature Infant
Surfactant
Eligibility:
All Genders
26-34 years
Brief Summary
To develop a comprehensive 'Clinical RD score' for decision making for administration of Surfactant in respiratory distress syndrome in preterm infants with gestation of 26 0/7 - 34 6/7 weeks and to a...
Detailed Description
Respiratory distress syndrome, also known as hyaline membrane disease, occurs almost exclusively in premature infants. The incidence and severity of respiratory distress syndrome are inversely related...
Eligibility Criteria
Inclusion
- Neonates between 26 0/7-34 6/7 weeks of gestation who were delivered in the hospital with clinical diagnosis of respiratory distress syndrome were eligible for inclusion for the study.
Exclusion
- Major congenital malformation
- Antenatally diagnosed congenital heart disease in fetus.
- Hydrops fetalis
- Massive Pulmonary hemorrhage prior to enrolment
- Shock requiring vasopressor support prior to enrolment
- Non availability of CPAP/ventilator in the unit.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 23 2016
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT03273764
Start Date
January 1 2015
End Date
December 23 2016
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lady Hardinge Medical college
New Delhi, National Capital Territory of Delhi, India, 110001